MktsMarkets

DexCom, Inc.
NASDAQ: DXCMKey statistics
DXCM News
Stories mentioning DXCM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,191,900 | 1,259,600 | 1,209,300 | 1,157,100 | 1,036,000 | 1,113,500 | 994,200 | 1,004,300 |
| Cost of Goods Sold | 441,600 | 466,900 | 477,900 | 468,300 | 447,000 | 457,700 | 400,400 | 377,600 |
| Gross Profit | 750,300 | 792,700 | 731,400 | 688,800 | 589,000 | 655,800 | 593,800 | 626,700 |
| Operating Expenses | ||||||||
| Research & Development | 145,300 | 148,200 | 157,500 | 148,200 | 145,200 | 139,500 | 135,400 | 136,000 |
| Sales General & Admin | 349,700 | 321,500 | 331,400 | 328,000 | 310,100 | 327,400 | 306,400 | 332,700 |
| Total Operating Expenses | 495,000 | 469,700 | 488,900 | 476,200 | 455,300 | 466,900 | 441,800 | 468,700 |
| Operating Income (Loss) | 255,300 | 323,000 | 242,500 | 212,600 | 133,700 | 188,900 | 152,000 | 158,000 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 14,200 | 17,700 | 109,800 | 28,500 | 20,600 | 22,400 | 25,400 | 29,800 |
| Pretax Income | 269,500 | 340,700 | 352,300 | 241,100 | 154,300 | 211,300 | 177,400 | 187,800 |
| Tax Provision | 70,000 | 73,400 | 68,500 | 61,300 | 48,900 | 59,600 | 42,800 | 44,300 |
| Net Income (Loss) | 199,500 | 267,300 | 283,800 | 179,800 | 105,400 | 151,700 | 134,600 | 143,500 |
| Earnings Per Share (Basic) | 0.52 | 0.69 | 0.73 | 0.46 | 0.27 | 0.39 | 0.34 | 0.36 |
| Earnings Per Share (Diluted) | 0.51 | 0.66 | 0.70 | 0.45 | 0.27 | 0.37 | 0.34 | 0.35 |
| Weighted Average Shares Outstanding (Basic) | 385,100 | 390,200 | 391,100 | 392,100 | 391,100 | 393,600 | 394,200 | 399,200 |
| Weighted Average Shares Outstanding (Diluted) | 393,600 | 405,500 | 407,400 | 408,200 | 407,500 | 412,700 | 410,200 | 416,800 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DXCM
DexCom, Inc. (NASDAQ: DXCM) is a stock listed on the Nasdaq Stock Market under the ticker symbol DXCM. It last traded at $80.19 (Nov 19, 2026, 4:00 PM ET), down 2.8% on the day. That gives DexCom a market capitalisation of $30.8B and a price-to-earnings ratio of 31.1.
Over the past 52 weeks DXCM has traded between $56.72 and $92.59.
Revenue for the quarter ended Mar 31, 2026 was $1.2B; net income $199.5M. Revenue was up 15.0% from $1.0B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.2B | $199.5M | 16.7% |
| Dec 31, 2025 | $1.3B | $267.3M | 21.2% |
| Sep 30, 2025 | $1.2B | $283.8M | 23.5% |
| Jun 30, 2025 | $1.2B | $179.8M | 15.5% |
From DexCom’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…